The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
about
Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisPhytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet.Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.Nonalcoholic fatty liver disease: Evolving paradigms.Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus.Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3-FOXO3a pathway.Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver
P2860
Q28354735-BB358A00-770A-4CB3-8836-6CD6DD0017E9Q37627658-19A87539-3A5E-4D7C-8519-23EFDE0D24C8Q38595252-C62D2F30-5644-4A5E-873D-9B39EC0BA3A4Q38670507-E3114865-B978-48D2-847A-EC4DF5C807C2Q42695154-9DA78F0A-2A19-40D6-9C4F-6E2F1FA8EDBEQ43162911-AFE9AB91-B70F-4AEA-B776-456FD2D3984FQ46624099-C71D9066-FE5C-48A4-8E45-8AA99BBD0289Q47093545-558A9C8A-347A-4BEC-8CED-52D7895ECF81Q50147806-30AD7B8F-2658-4B86-A18C-86B3B8B443AAQ58799660-5B3ECC49-BF52-411C-B353-9FE697B3209F
P2860
The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@en
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@nl
type
label
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@en
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@nl
prefLabel
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@en
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@nl
P2093
P2860
P356
P1476
The xanthine oxidase inhibitor ...... tohepatitis in a rodent model.
@en
P2093
Aya Katasako
Hideaki Kamata
Hideyuki Sakoda
Keiichi Mori
Midori Fujishiro
Ryuhei Kanaoka
Takeshi Yamamotoya
Tomoichiro Asano
Toshiaki Fukushima
Yasuka Matsunaga
P2860
P304
P356
10.1152/AJPGI.00443.2014
P577
2015-05-21T00:00:00Z